Powerful protein-based approach and innovative Matrix Adjuvant technology

Novavax creates transformational vaccines that address some of the world’s most pressing infectious diseases

Our approach to science

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to help prevent serious infectious diseases.

Our proprietary protein vaccine platform and adjuvant technology can be applied to address current and emerging global health threats.

red jelly spheres

Matrix-M™ adjuvant technology

Our saponin-based Matrix-M™ adjuvant enhances the immune response and has a dose-sparing effect, both of which are critical to successful vaccine development.


Recombinant nanoparticle vaccine technology

We are committed to delivering novel products that leverage cutting edge recombinant protein nanoparticles to protect against a broad range of infectious diseases.

orange antigens image

Science & Technology

Our pipeline—creating tomorrow's vaccine today

Science & Technology